Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead

wsj.com/health/pharma/novo-nordisk-ozempic-eli-lilly-c7ac45ae

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only getting wider.

This story appeared on wsj.com, 2025-04-30 09:30:00.
The Entire Business World on a Single Page. Free to Use →